Tristel (LON:TSTL) Stock Crosses Below 200-Day Moving Average of $451.13

Tristel plc (LON:TSTL) shares passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 451.13 ($5.73) and traded as low as GBX 435.35 ($5.53). Tristel shares last traded at GBX 437.50 ($5.56), with a volume of 23,303 shares traded.

Tristel Price Performance

The stock has a market cap of £207.99 million, a PE ratio of 3,365.38 and a beta of 0.26. The stock’s fifty day moving average is GBX 444.41 and its 200-day moving average is GBX 451.13. The company has a debt-to-equity ratio of 19.12, a current ratio of 4.92 and a quick ratio of 3.83.

Insider Activity

In other news, insider Elizabeth Dixon sold 29,000 shares of the firm’s stock in a transaction that occurred on Tuesday, June 11th. The stock was sold at an average price of GBX 440 ($5.59), for a total value of £127,600 ($162,134.69). In other news, insider Paul Christopher Swinney sold 50,000 shares of Tristel stock in a transaction that occurred on Tuesday, April 16th. The shares were sold at an average price of GBX 462 ($5.87), for a total transaction of £231,000 ($293,519.70). Also, insider Elizabeth Dixon sold 29,000 shares of the firm’s stock in a transaction dated Tuesday, June 11th. The stock was sold at an average price of GBX 440 ($5.59), for a total transaction of £127,600 ($162,134.69). Insiders own 5.29% of the company’s stock.

About Tristel

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand.